Latest News
Big Tech Offers to Fund SK Hynix Fabs Amid AI Memory Shortage
Global tech giants are offering to finance SK hynix's new fabs and equipment to lock in high-bandwidth memory supply, as AI-driven demand pushes capacity to zero and prices double.
Everpure Director Sells $10M in Shares Ahead of Q1 Earnings
Everpure director John Colgrove sold 134,265 Class A shares for about $10.09 million ahead of the company's fiscal Q1 2027 earnings report.
Aehr Test Systems Rises on Record AI Chip Order, Despite Revenue Drop
Aehr Test Systems shares rose 6.5% on a record $41M AI chip order. Q3 revenue fell 44% to $10.3M, but bookings reached $37.2M, pointing to future growth.
Whirlpool Ends 70-Year Dividend Streak as Profit Forecast Slashed
Whirlpool suspends its long-standing dividend and slashes 2026 profit outlook after a tough first quarter, sending shares to a 14-year low.
Sandisk Shares Rally 16.5% as AI Flash Storage Demand Skyrockets
Sandisk shares jumped 16.5% to $1,562.34, lifting market cap to $245 billion, as AI-driven flash storage demand boosted Q3 revenue 97% sequentially to $5.95 billion.
Enterprise Products Units Dip on Revenue Decline Despite Record Volumes
Enterprise Products Partners units slipped 1.4% to $37.19 after a quarterly filing showed Q1 revenue fell to $14.39B while net income rose. Record volumes and a $0.55 distribution are key.
Linde's €1.6B Bond Issue Highlights Strong Project Backlog
Linde raised €1.6B in euro bonds after a Q1 profit beat and raised 2026 outlook. The move supports its $7.1B project backlog and shareholder returns.
Intuitive Machines Surges 20% Ahead of Lunar Mission and Earnings
Intuitive Machines shares surged 20.2% to $28.97, reversing a prior drop, ahead of its Q1 earnings report and a key lunar mission test.
Everspin Shares Jump on $40M Defense MRAM Award, Strong Q1 Sales
Everspin Technologies shares jumped 25.5% Friday following a $40 million U.S. defense MRAM deal and stronger Q1 sales. The stock closed at $26.99 and traded at $36.05 after hours.
Moderna Stock Jumps 12% on Hantavirus Vaccine Deal; Flu and Cancer Pipeline in Focus
Moderna shares rose 11.9% to $54.35 after the company disclosed early-stage hantavirus vaccine research with the U.S. Army and Korea University, following a deadly outbreak on the MV Hondius cruise ship.